Maxwell Finland Professor of Medicine, Microbiology and Molecular Genetics
Infectious Disease
Dr. Raphael Dolin, MD
|
|
Give Review
Dr. Raphael Dolin practices Infectious Disease. He graduated from Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He has 2 awards "Elected Member" and "Whos Who in Medicine and Healthcare". Doctor Raphael Dolin, MD has written publications. He has 25 publications published with PubMed. The lastest publication is: 'Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans.'
Publications
- Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans.
- First-in-Human Evaluation of a Hexon Chimeric Adenovirus Vector Expressing HIV-1 Env (IPCAVD 002).
- Novel HIV vaccine strategies: overview and perspective.
- The quadrivalent approach to influenza vaccination.
- Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial.
- Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).
- First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001).
- Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses.
- Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Gr...
- Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. 1971.
- Influenza--interpandemic as well as pandemic disease.
- Noroviruses--challenges to control.
- A new class of anti-HIV therapy and new challenges.
- The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays.
- Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys.
- HIV vaccine trial results--an opening for further research.
- Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax.
- Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration.
- Editorial commentary: Perspectives on the role of immunization against influenza in HIV-infected patients.
- Resistance to neuraminidase inhibitors.
- International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations.
- Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.
- A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204).
- Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects.
Schools
Harvard Medical School
Boston City Hospital
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Elected Member
- Whos Who in Medicine and Healthcare
Education
-
Boston University Medical Center -
Harvard Medical School
Hospital
-
Beth Israel Deaconess Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Alissa J. Wright, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth M. Kaye, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Herce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter F. Weller, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Lorne N. Small, MD
This Doctor is OpenDoctor Recommended.
|